| ROI 1 | ROI 7 | ROI total | ||||||
---|---|---|---|---|---|---|---|---|---|
Coefficient | Standard error | P value | Coefficient | Standard error | P value | Coefficient | Standard error | P value | |
Age | − 0.080 | 0.035 | 0.023 | 0.033 | 0.035 | 0.346 | − 0.020 | 0.027 | 0.454 |
Gender | − 1.518 | 0.642 | 0.018 | − 0.856 | 0.763 | 0.262 | − 0.005 | 0.588 | 0.993 |
History of anti-osteoporosis treatment | − 1.635 | 0.848 | 0.054 | 0.497 | 0.991 | 0.616 | 0.132 | 0.763 | 0.863 |
BMI | − 0.027 | 0.067 | 0.687 | 0.012 | 0.077 | 0.877 | − 0.144 | 0.071 | 0.042 |
Diagnosis 1 (transform into dummy variable) | 1.687 | 1.016 | 0.097 | 0.934 | 1.006 | 0.353 | 0.805 | 0.847 | 0.342 |
Diagnosis 2 (transform into dummy variable) | − 1.198 | 0.989 | 0.226 | − 1.949 | 1.031 | 0.059 | − 1.420 | 0.892 | 0.111 |
Diagnosis 3 (transform into dummy variable) | − 1.220 | 0.659 | 0.064 | − 0.685 | 0.772 | 0.375 | − 1.532 | 0.658 | 0.02 |
MNA-SF score | 0.499 | 0.364 | 0.170 | − 0.148 | 0.397 | 0.709 | − 0.097 | 0.320 | 0.762 |
Preoperative lumbar BMD | − 2.910 | 2.819 | 0.302 | 2.483 | 3.061 | 0.417 | 0.719 | 2.512 | 0.775 |
Preoperative hip BMD | − 1.197 | 2.604 | 0.646 | − 8.550 | 3.124 | 0.006 | − 3.161 | 2.275 | 0.165 |
Serum ALP | − 0.017 | 0.013 | 0.180 | − 0.001 | 0.015 | 0.949 | − 0.018 | 0.012 | 0.154 |
Serum Ca | − 4.608 | 2.922 | 0.115 | − 0.849 | 3.065 | 0.782 | 0.107 | 2.624 | 0.967 |
Preoperative Harris score | 0.010 | 0.018 | 0.569 | 0.044 | 0.020 | 0.030 | 0.005 | 0.017 | 0.751 |
Implant design of femoral component | 0.136 | 0.750 | 0.857 | 0.277 | 0.739 | 0.708 | 1.655 | 0.768 | 0.031 |
BMD of ROI 1 at 1 week after THA | 7.012 | 2.715 | 0.010 | / | / | / | / | / | / |
BMD of ROI 7 at 1 week after THA | / | / | / | 10.658 | 2.389 | < 0.001 | / | / | / |
BMD of ROI total at 1 week after THA | / | / | / | / | / | / | 5.705 | 2.461 | 0.020 |